当前位置: 首页 > 期刊 > 《中国当代医药》 > 2016年第33期 > 正文
编号:12984349
mTOR信号通路在缺血性心脏病中的研究进展(5)
http://www.100md.com 2016年11月25日 《中国当代医药》2016年第33期
     [21]Volkers M,Konstandin MH,Doroudgar S,et al.Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage[J].Circulation,2013,128(19):2132-2144.

    [22]Mathew J,Sleight P,Lonn E,et al.Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enz?鄄yme inhibitor ramipril[J].Circulation,2001,104(14):1615-1621.

    [23]Xu X,Hua Y,Nair S,et al.Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy[J].Hypertension,2014,63(3):490-499.

    [24]Chen H,Wang X,Tong M,et al.Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy[J].PLoS One,2013,8(5):e64757.

    [25]Soesanto W,Lin HY,Hu E,et al.Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats[J].Hypertension,2009,54(6):1321-1327.

    [26]Bishu K,Ogut O,Kushwaha S,et al.Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade[J].PLoS One,2013,8(12):e81325.

    [27]Li MH,Zhang YJ,Yu YH,et al.Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy[J].Eur J Pharmacol,2014,728:67-76.

    (收稿日期:2016-10-26 本文編辑:顾雪菲) (杨资鉴 秦富忠)
上一页1 2 3 4 5